Since 2009 SUKL Bulletin is published in electronic form. Full version is available on the czech webpage.
Contents:
- Measures taken in the case of quality defects or adverse reactions to medicinal productsin the month of April 2009
- List of guidelines valid as of May 1, 2009
- State Institute for Drug Control informs on extension of shelf life for the medicinal product Tamiflu
- Outline of notifications on the use of non-authorised medicinal products in the month of April 2009
- List of authorised medicinal products where placing on the market of individual batches with the labellingin a foreign language was approved in the month of April 2009
- Information on Czech standards relating to medical devices published in the Bulletin of the COSMT
- Information on documents issued by the European Medicines Agency (EMEA)
- Data on applications submitted to SUKL – marketing authorisations and variations thereto
- Overview of data on applications submitted in the first quarter of 2009 – clinical trials
- Overview of data on basic activities of the Section of Pharmacy and Distribution Controlin the first quarter of 2009
- Overview of data on basic activities of the Inspection Section in the first quarter of 2009
- Overview of data on activities of the Surveillance Branch in the area of medical devicesin the first quarter of 2009
- List of manufacturers and distributors of pharmaceuticals in the CR approved in the month of April 2009
- List of medicinal products whose marketing authorisation will expire in July 2009
- List of medicinal products with expired marketing authorisation
- Revocations of marketing authorisations in the period from February 19, 2009 to March 18, 2009
- Authorised medicinal products and variations to marketing authorisations approved in the year 2009
- Medicinal products authorised under the EU centralised procedure and enteredin SUKL database in the year 2009
- List of specific therapeutic programmes approved in the period from April 1, 2009 to April 30, 2009